Published on 01 January 2022

A Phase III, Prospective, Multicenter, Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Cervical Dystonia

View Dataset
Ipsen

Description

The aim of this study is to assess longer term safety and effectiveness of Dysport®.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.3

FAIR Score

31%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Vivli

Assigned Domain

Subfield

Molecular Biology

Field

Biochemistry, Genetics and Molecular Biology

Domain

Life Sciences

Confidence Score

46%

Source

Scholar Data Model

Keywords

Conditions: Cervical DystoniaInterventions: Botulinum toxin type A

Normalization Factors

FT

30.77

CTw

1.00

MTw

1.00